SLONIN JONATHAN 4
4 · Pacira BioSciences, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
SLONIN JONATHAN
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-01-06$18.40/sh−879$16,174→ 93,443.511 total - Tax Payment
Common Stock
2025-01-02$18.33/sh−371$6,800→ 94,322.511 total
Footnotes (3)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes 386.765 shares of common stock acquired under the issuer's employee stock purchase plan in December 2024.
- [F3]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.